News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
SR Pharma PLC Gets Encouraging Results In Mice For Pancreatic Cancer Drug
September 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (AFX) - SR Pharma plc said it and its operating subsidiary Atugen AG have received encouraging results in mice under studies on the therapeutic efficacy of Atu027 RNAi treating pancreatic cancer.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
Insights
From sequence to scale: Gene editing’s new era in biologics manufacturing
July 10, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
July 10, 2026
·
1 min read
·
Gabrielle Masson
Cardiovascular disease
AstraZeneca, Ionis’ Wainua woes send waves across ATTR-CM space
July 10, 2026
·
3 min read
·
Tristan Manalac
Huntington’s disease
Roche scraps 2 Huntington’s studies, handing Ionis more bad news
July 10, 2026
·
2 min read
·
Tristan Manalac
